Understanding immunotherapy and its management
<p>A few tumours are exceptionally stubborn to oral chemotherapy. The endurance of tumours in a few cases is helped by checkpoint immunomodulation to keep up the unevenness between resistant reconnaissance and disease cell division. Checkpoint counteracting agent inhibitors, for example, again...
Zapisane w:
Główni autorzy: | Nadiminti Rajesh Kumar (Autor), Sajid Alvi (Autor) |
---|---|
Format: | Książka |
Wydane: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2021-01-12.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Podobne zapisy
-
Immunotherapy and its advances in the management of head-and-neck cancer
od: Sajad Ahmad Buch, i wsp.
Wydane: (2019) -
Nanotechnology for boosting ovarian cancer immunotherapy
od: Prabhjot Kaur, i wsp.
Wydane: (2024) -
Cancer immunotherapy and its facilitation by nanomedicine
od: Chao Sui, i wsp.
Wydane: (2024) -
Adverse Events of Oncologic Immunotherapy and Their Management
od: Fedricker Diane Barber
Wydane: (2019) -
CANCER IMMUNOLOGY AND IMMUNOTHERAPY - UNDERSTANDING AND ADAPTATION THE CURRENT EVIDENCE TO OPTIMIZE PATIENT THERAPY OUTCOMES.
od: Orlin Savov, i wsp.
Wydane: (2015)